The solution incorporates computer vision to support the clinical assessment of a condition affecting nearly 500 people in Cantabria. The Marqués de Valdecilla Research Institute (IDIVAL), the University of Cantabria (UC) and Viacore IT have developed an innovative application that facilitates the treatment of diabetic foot for healthcare professionals without specialized podiatry training. Thanks to […]
The Marqués de Valdecilla Research Institute (IDIVAL) has successfully passed its annual certification audit, held on April 9th and 10th, reaffirming its commitment to the highest standards of quality and innovation. The external evaluation has renewed the institute’s certification under the UNE 166.002:2021 standard, relating to R&D&I Management, and the UNE-EN ISO 9001:2015 standard, a […]
A team of researchers from the Valdecilla Research Institute (IDIVAL) and the University of Cantabria has developed a targeted nanomedicine capable of selectively delivering chemotherapy to tumors, avoiding toxic effects on healthy tissues. The study, which reports promising preclinical results, has been published in the prestigious journal Small. The Nanomedicine Group at IDIVAL and the […]
Cantabria’s Most Important Healthcare Event Will Take Place on June 10–11 at Espacio Comillas, Universidad de Comillas On June 10 and 11, 2025, Universidad de Comillas will become the epicenter of healthcare debate and innovation in Cantabria with the celebration of the 15th Patient Safety and Quality Conference, which this year will be held alongside […]
The Marqués de Valdecilla University Hospital (HUMV) and the IDIVAL Health Research Institute are advancing in the multicenter clinical trial CASSANDRA, which evaluates in humans the experimental drug IDP-121, a direct cMyc inhibitor — a key protein involved in the development of most cancers. This phase I/II study is aimed at patients with Multiple Myeloma, […]
The research, conducted by professionals from the Marqués de Valdecilla University Hospital and researchers from the IDIVAL Health Research Institute, evaluates the usefulness of the GAP index as a prognostic marker in patients with interstitial lung diseases referred for transplantation. Researchers from the Marqués de Valdecilla Research Institute (IDIVAL), in collaboration with the Pulmonology Department […]
This Sunday, April 27, the Municipal Stadium of Los Corrales de Buelna will host one of Cantabria’s largest solidarity events: the 15th edition of “Luchamos por la vida” (“We Fight for Life”). Every year, this initiative brings together sports, social commitment, and support for scientific research — and this time, it returns with an ambitious […]
A team from the Immunopathology Group at IDIVAL, the University of Cantabria, and the Cantabrian Health Service has discovered a relationship between bone metabolism and vulnerability to SARS-CoV-2. The study, led by Drs. Emilio Pariente and José Luis Hernández, was recently published in the scientific journal Current Medical Research and Opinion and sheds light on […]
The Marqués de Valdecilla Research Institute Foundation (IDIVAL) has launched the hiring process for a team of 10 professionals who will lead the implementation of the ambitious project VALDATA: Cantabria Towards a Health Data Economy. The initiative, backed by €1.7 million in funding from the 2023 Sectoral Data Spaces Programme — financed through the Recovery, […]
This Monday, the Marqués de Valdecilla Research Institute (IDIVAL) welcomed Glòria Oliver Rodríguez, Deputy Director General of the Pasqual Maragall Foundation, and Joan Vives i Tomàs, Administrative Director of the Centre for Genomic Regulation (CRG). During their visit to IDIVAL’s headquarters in Santander, they held a meeting with Galo Peralta Fernández, Managing Director, Marcos López […]
